☰ Accessibility
November 3, 2025

The Indian government has extended the relaxation on stainless steel imports, allowing the sale of non-BIS-compliant (non-Bureau of Indian Standards) steel products until December 31, 2025. The decision, aimed at easing raw material shortages, has received mixed reactions — welcomed by import-dependent industries but opposed by domestic manufacturers…

November 3, 2025

Resonance Specialties Limited has reported strong financial performance for the second quarter of FY26, driven by consistent demand in both domestic and international markets. The company recorded significant year-on-year growth in revenue and profitability, reflecting its operational efficiency and export-led expansion. Key Financial Highlights Metric Q2 FY26 Q2…

November 3, 2025

IndusInd International Holdings Ltd (IIHL), part of the Hinduja Group, has officially commenced its joint venture with US-based Invesco Ltd by acquiring a 60% stake in Invesco Asset Management India (IAMI). This partnership aims to strengthen mutual fund distribution and investment access across India, leveraging the combined expertise…

November 3, 2025

In a landmark development for India’s technology sector, Union Minister Ashwani Vaishnaw has announced the start of semiconductor production at manufacturing facilities operated by Kaynes Technology India and CG Power. The move marks a major leap toward India’s goal of becoming a global semiconductor manufacturing hub, aimed at…

November 3, 2025

Tata Capital Limited, the flagship financial services arm of the Tata Group, has announced a strategic partnership with the Green Climate Fund (GCF) under the BEACON INDIA Programme, aimed at supporting early-stage climate-focused start-ups across India. The programme combines a USD 15.85 million revolving facility and a USD…

November 3, 2025

Ajanta Pharma Limited announced its financial results for the second quarter of FY26, reporting solid performance across key business segments, particularly in branded generics and international markets. The company also declared an interim dividend of ₹28 per share for FY26. Financial Performance Overview Ajanta Pharma’s branded generics business…